207 related articles for article (PubMed ID: 17869274)
21. Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells.
Borger JG; Zamoyska R; Gakamsky DM
Immunol Lett; 2014; 157(1-2):16-22. PubMed ID: 24263053
[TBL] [Abstract][Full Text] [Related]
22. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
Denkberg G; Cohen CJ; Reiter Y
J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
[TBL] [Abstract][Full Text] [Related]
23. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
[TBL] [Abstract][Full Text] [Related]
24. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
Wooldridge L; Scriba TJ; Milicic A; Laugel B; Gostick E; Price DA; Phillips RE; Sewell AK
Eur J Immunol; 2006 Jul; 36(7):1847-55. PubMed ID: 16783852
[TBL] [Abstract][Full Text] [Related]
25. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
[TBL] [Abstract][Full Text] [Related]
26. Avidity characterization of genetically engineered T-cells with novel and established approaches.
Hillerdal V; Boura VF; Björkelund H; Andersson K; Essand M
BMC Immunol; 2016 Jul; 17(1):23. PubMed ID: 27411667
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes.
Uhlin M; Masucci MG; Levitsky V
Scand J Immunol; 2003 Feb; 57(2):99-106. PubMed ID: 12588655
[TBL] [Abstract][Full Text] [Related]
28. The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.
Laugel B; Cole DK; Clement M; Wooldridge L; Price DA; Sewell AK
J Leukoc Biol; 2011 Dec; 90(6):1089-99. PubMed ID: 21954283
[TBL] [Abstract][Full Text] [Related]
29. CD8 controls T cell cross-reactivity.
Wooldridge L; Laugel B; Ekeruche J; Clement M; van den Berg HA; Price DA; Sewell AK
J Immunol; 2010 Oct; 185(8):4625-32. PubMed ID: 20844204
[TBL] [Abstract][Full Text] [Related]
30. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.
Cawthon AG; Alexander-Miller MA
J Immunol; 2002 Oct; 169(7):3492-8. PubMed ID: 12244138
[TBL] [Abstract][Full Text] [Related]
31. T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.
Flerin NC; Chen H; Glover TD; Lamothe PA; Zheng JH; Fang JW; Ndhlovu ZM; Newell EW; Davis MM; Walker BD; Goldstein H
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077649
[TBL] [Abstract][Full Text] [Related]
32. TCR internalization induced by peptide/MHC ligands requires the transmembrane domains of alphabeta chains of TCR, but not the expression of CD8 and Thy-1 molecules.
Lee MH; Min D; Sonn CH; Lee KN; Kim KE; Paik SG; Kim YS
Mol Cells; 1999 Dec; 9(6):617-24. PubMed ID: 10672928
[TBL] [Abstract][Full Text] [Related]
33. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
[TBL] [Abstract][Full Text] [Related]
34. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics.
Wyer JR; Willcox BE; Gao GF; Gerth UC; Davis SJ; Bell JI; van der Merwe PA; Jakobsen BK
Immunity; 1999 Feb; 10(2):219-25. PubMed ID: 10072074
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometry-based TCR-ligand Koff -rate assay for fast avidity screening of even very small antigen-specific T cell populations ex vivo.
Nauerth M; Stemberger C; Mohr F; Weißbrich B; Schiemann M; Germeroth L; Busch DH
Cytometry A; 2016 Sep; 89(9):816-25. PubMed ID: 27564267
[TBL] [Abstract][Full Text] [Related]
36. Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.
Denton AE; Wesselingh R; Gras S; Guillonneau C; Olson MR; Mintern JD; Zeng W; Jackson DC; Rossjohn J; Hodgkin PD; Doherty PC; Turner SJ
J Immunol; 2011 Dec; 187(11):5733-44. PubMed ID: 22039305
[TBL] [Abstract][Full Text] [Related]
37. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor.
Gao GF; Jakobsen BK
Immunol Today; 2000 Dec; 21(12):630-6. PubMed ID: 11114424
[TBL] [Abstract][Full Text] [Related]
38. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
Aleksic M; Dushek O; Zhang H; Shenderov E; Chen JL; Cerundolo V; Coombs D; van der Merwe PA
Immunity; 2010 Feb; 32(2):163-74. PubMed ID: 20137987
[TBL] [Abstract][Full Text] [Related]
39. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
[TBL] [Abstract][Full Text] [Related]
40. Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.
Bernardeau K; Gouard S; David G; Ruellan AL; Devys A; Barbet J; Bonneville M; Chérel M; Davodeau F
Eur J Immunol; 2005 Oct; 35(10):2864-75. PubMed ID: 16163672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
